Lung Cancer

The AJMC® Lung Cancer compendium is a comprehensive resource for clinical news and expert insights for the condition.

Diet Created to Lower Diabetes Risk Linked With Reduced Lung Cancer Incidence

May 17th 2022, 3:36pm


The findings are based off an analysis of 98,159 individuals.

Study Finds Rural Residence May Adversely Influence Lung Cancer Screening Among Veterans

May 12th 2022, 9:45pm


Veterans residing in rural areas were less likely to complete annual repeat lung cancer screenings compared with those living in a nonrural location, with reduced uptake of initial lung cancer screening also found among eligible veterans in rural vs nonrural locations.

Survival Varies Little by Surgery Type in NSCLC With Micro Lesions

May 9th 2022, 5:17pm


A subsequent analysis suggested, however, that segmentectomy was preferable to lobectomy in many cases.

Meta-analysis Finds Link Between Emphysema Severity, Lung Cancer Risk

May 3rd 2022, 2:05pm


A new meta-analysis found that more severe emphysema is associated with an increased risk of lung cancer.

Review Outlines Advancements in Precision Therapy for Metastatic Lung Cancer

May 1st 2022, 3:53pm


A new review article summarizes current approaches to precision medicine in lung cancer.

Study Finds Risk of Overinvestigation in Patients With Lung Cancer Not Fit for Anticancer Treatment

April 30th 2022, 7:43pm


Among a group of patients with lung cancer who were not suitable for anticancer treatment, the researchers found that 40% underwent additional investigations after their initial CT scan before eventually receiving best supportive care.

Outreach Efforts Increased Lung Cancer Screening in Primary Care Settings

April 29th 2022, 3:53pm


Researchers in Pennsylvania conducted a randomized controlled trial to understand the effect of patient outreach on lung cancer screening rates.

Dr Melissa Johnson Highlights Potential Lung Cancer Treatments in the Pipeline

April 26th 2022, 3:40pm


Melissa Johnson, MD, program director of Lung Cancer Research at Sarah Cannon, discusses the potential of certain drug classes for lung cancer.

New Study Details Frequency of SDOH Documentation Among Patients With Lung Cancer

April 22nd 2022, 9:06pm


A decade’s worth of data included more than 5 million social determinants of health (SDOH) attributes across nearly 2 million clinical notes from the patient visits extrapolated from a natural language processing system.

Dr Davey Daniel on Barriers Limiting Genomic Testing Use in Lung Cancer

April 17th 2022, 3:20pm


Davey Daniel, MD, chief medical officer, OneOncology, speaks on the knowledge, infrastructure, and payer-related barriers that are limiting the use of genomic testing in the management of patients with lung cancer.